Bruce Kovner, Director, 10% Owner at SYNTA PHARMACEUTICALS CORP (SNTA), bought 37,700 shares at $6.95 ($260K) on 2012-11-14, disclosed to the SEC on 2012-11-14.
Open-market purchase of $260k SNTA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.89 | 27,200 | $187K | 72.0% |
| 2 | $6.95 | 10,500 | $73K | 28.0% |
| Total | $6.91 avg | 37,700 | $260K | 100% |
| Filing → |
| SBBP | BUY | 2018-12-21 | $1.3M | — | Filing → |
| SBBP | BUY | 2018-08-09 | $3.6M | — | Filing → |
| SBBP | BUY | 2018-07-27 | $2.6M | — | Filing → |